Literature DB >> 1984562

Effect of obesity and body fat distribution on sex hormones and insulin in men.

R Pasquali1, F Casimirri, S Cantobelli, N Melchionda, A M Morselli Labate, R Fabbri, M Capelli, L Bortoluzzi.   

Abstract

To investigate the relationship between body fat distribution, sex hormones, and hyperinsulinemia in male obesity, we examined 52 obese men (body mass index [BMI], 35.0 +/- 6.1, mean +/- SD) and 20 normal-weight controls. Their waist to hip circumference ratio (WHR), which was used as an index of fat distribution, was 0.985 +/- 0.052 and 0.913 +/- 0.061 (P less than .005), respectively. Compared with controls, obese men presented significantly lower levels of total (357 +/- 132 v 498 +/- 142 ng/dL; P less than .005) and free testosterone (14.2 +/- 2.9 v 17.1 +/- 2.6 pg/mL; P less than .05) and sex hormone-binding globulin (SHBG; 41.7 +/- 31.9 v 66.2 +/- 18.6 nmol/L; P less than .001) without any significant difference on the other sex steroid or on gonadotropin concentrations. Fasting and glucose-stimulated insulin and C-peptide levels were significantly higher in obese than in controls, and in obese with the WHR value greater than 0.97 (corresponding to the distribution median) than in those with WHR lower or equal to 0.97. BMI was negatively correlated with testosterone (P less than .005), free testosterone (P less than .01), and SHBG (P less than .001) and positively with fasting (P less than .001) and glucose-stimulated (P less than .005) C-peptide concentrations, whereas no relationship was found between these variables and WHR values. On the contrary, WHR was significantly correlated with fasting and post-glucose insulin levels (P less than .05), but not with those of sex steroids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984562     DOI: 10.1016/0026-0495(91)90199-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  54 in total

1.  Effects of abstinence on sex hormone profile in alcoholic patients without liver failure.

Authors:  H Iturriaga; L Valladares; S Hirsch; E Devoto; C P'erez; D Bunout; X Lioi; M Petermann
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Comparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patients.

Authors:  Seung Hwan Lee; Cheol Young Oh; Kyung Kgi Park; Mun Su Chung; Se Jeong Yoo; Byung Ha Chung
Journal:  Asian J Androl       Date:  2011-04-18       Impact factor: 3.285

3.  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

4.  Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.

Authors:  Sabine Rohrmann; Meredith S Shiels; David S Lopez; Nader Rifai; William G Nelson; Norma Kanarek; Eliseo Guallar; Andy Menke; Corinne E Joshu; Manning Feinleib; Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2011-06-16       Impact factor: 2.506

5.  Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum in Men and Women From The Baltimore Longitudinal Study of Aging.

Authors:  Elisa Fabbri; Yang An; Marta Gonzalez-Freire; Marco Zoli; Marcello Maggio; Stephanie A Studenski; Josephine M Egan; Chee W Chia; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-02-27       Impact factor: 6.053

6.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

Authors:  E Ferrannini; A Natali; P Bell; P Cavallo-Perin; N Lalic; G Mingrone
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 7.  Testosterone therapy in men: clinical and pharmacological perspectives.

Authors:  A Gambineri; R Pasquali
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

8.  Effects of obesity on lower urinary tract symptoms in Korean BPH patients.

Authors:  Seung Hwan Lee; Joon Chul Kim; Ji-Youl Lee; Jang Hwan Kim; Cheol Young Oh; Seung Wook Lee; Se Jeong Yoo; Byung Ha Chung
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

Review 9.  The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Authors:  Abdulmaged M Traish; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.